title: HIV infection and pathogenesis: what about chemokines?
abstract: Several chemotactic cytokines, or chemokines. inhibit HIV replication by blocking or down regulating chemokine receptors that serve as entry cofactors for the virus. Although the role of chemokine receptors in HIV pathogenesis has been the subject of intense interest, chemokines are comparatively less seriously considered as potential correlates of protection from HIV infection and disease progression. However, a critical analysis of newly available data reveals substantial evidence to support a beneficial role for chemokines in HIV infection and disease. In this review we summarize the results of such studies and their promising implications for HIV infection.
authors.affiliation: University of Maryland Biotechnology Institute, University of Maryland, Baltimore 21201-1192, USA. coleman@umbi.umd.edu
authors.forename: R C
authors.initials: RC
authors.lastname: Gallo
authors.forename: A
authors.initials: A
authors.lastname: Garzino-Demo
authors.forename: A L
authors.initials: AL
authors.lastname: DeVico
mesh_terms: D000818:Animals; D018925:Chemokines / Q000502:physiology* / Q000627:therapeutic use; D006678:HIV / Q000276:immunology* / Q000472:pathogenicity; D015658:HIV Infections / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000378:metabolism; D006801:Humans
chemical_list: D018925:Chemokines